HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.

Abstract
A randomized, blinded, pilot study of influenza vaccine administered to children attending day care centers was conducted during the 1996-1997 winter. Vaccine efficacy in preventing serologically proven influenza virus infection was 0.45 (95% confidence limit [CL]: -0.02, 0.69) for influenza B and 0.31 (95% CL: -0.95, 0.73) for influenza A(H3N2). For both influenza A(H3N2) and B, children without preexisting hemagglutination inhibition (HI) antibody to these antigens had lower antibody responses to vaccine, were less likely to develop a serological response, and were more likely to develop serological evidence of influenza infection. Although there were no reductions in respiratory or febrile respiratory illnesses among all vaccinated children, there was a trend for reductions in such illnesses among vaccinated children with preexisting HI antibodies to influenza A(H3N2) and B. Therefore, immunologic priming in young children may be important for vaccine response and for protection against infection. Larger studies are needed in other influenza seasons to assess vaccine efficacy and clinical effectiveness.
AuthorsE S Hurwitz, M Haber, A Chang, T Shope, S T Teo, J S Giesick, M M Ginsberg, N J Cox
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 182 Issue 4 Pg. 1218-21 (Oct 2000) ISSN: 0022-1899 [Print] United States
PMID10979921 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Hepatitis A Vaccines
  • Influenza Vaccines
  • Vaccines, Inactivated
Topics
  • Antibodies, Viral (blood)
  • Child Day Care Centers
  • Child, Preschool
  • Double-Blind Method
  • Hemagglutination Inhibition Tests
  • Hepatitis A Vaccines
  • Humans
  • Influenza A virus (immunology)
  • Influenza B virus (immunology)
  • Influenza Vaccines (immunology, therapeutic use)
  • Influenza, Human (immunology, prevention & control)
  • Pilot Projects
  • Vaccines, Inactivated (immunology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: